Pantoprazol Sun Pharma (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Sun Pharma, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults. GNH USA supplies Pantoprazol Sun Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazol Sun Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Sun Pharma is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining. - Erosive esophagitis: heals the erosions in the esophagus. - Peptic ulcer disease: supports ulcer healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

Pantoprazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache. - Diarrhea. - Nausea. - Abdominal pain. - Flatulence. - Constipation.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, angio‑edema). - Clostridioides difficile‑associated colitis. - Low magnesium levels (hypomagnesemia). - Acute interstitial nephritis. - Fracture risk with long‑term use. - Liver enzyme elevations.

When prescribing Pantom​​  ​  ​  ​  ​  ​  ​  ​   ​    ​    ​   ...

-     \\  \\